Financial News Feed

Previous Hold Today ACST ranks #3452 as HOLD CANDIDATE. Next Hold
Today ACST ranks #3452 as HOLD CANDIDATE.

ACST stock Acasti Pharma

ACST stock
Acasti Pharma

Analysts expect Acasti Pharma Inc. (NASDAQ:ACST) to report $-0.08 EPS on February, 12.They anticipate $0.23 EPS change or 74.19 % from last quarter's $-0.31...

Read more

Zacks Investment Research downgraded shares of Acasti Pharma (NASDAQ:ACST) from a buy rating to a hold rating in a research note published on Monday. According to Zacks, “Acasti Pharma Inc. is a bio...

Read more

Zacks Investment Research lowered shares of Acasti Pharma (NASDAQ:ACST) from a buy rating to a hold rating in a report published on Monday morning. According to Zacks, “Acasti Pharma Inc. is a bioph...

Read more

Acasti Pharma (ACST) shares are on close watch heading into the week as the price has moved above the Balance Step indicator, revealing a potential near-term bullish uptrend. The Balance Step formula ...

Read more

Analysts expect Acasti Pharma Inc. (NASDAQ:ACST) to report $-0.08 EPS on February, 12.They anticipate $0.23 EPS change or 74.19 % from last quarter's $-0.31...

Read more

Acasti Pharma (NASDAQ:ACST) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Monday. According to Zacks, “Acasti P...

Read more

Zacks Investment Research cut shares of Acasti Pharma (NASDAQ:ACST) from a buy rating to a hold rating in a research report sent to investors on Monday morning. According to Zacks, “Acasti Pharma In...

Read more

Acasti Pharma (ACST) shares are being closely watched by investors as the Twiggs Money Flow indicator has jolted above the zero line. This typically indicates that further upside is ahead for the shar...

Read more

Acasti Pharma (ACST) shares are showing positive signals short-term as the stock has finished higher by 27.78% for the week. In taking a look at recent performance, we can see that shares have moved 7...

Read more

Successful stock market traders and investors don’t usually just become that way overnight. There are often many years of experience behind those winning trades. The amount of data available to inve...

Read more

Acasti Pharma (ACST) is seeing positive money flow as the Chalkin (CMF) indicator is holding above the zero line. The Chaikin Money Flow Indicator is an oscillator developed by Marc Chaikin. An oscill...

Read more

Monitoring the indicators for Acasti Pharma (ACST), we have noticed that the Plus Directional Indicator is currently higher than the Minus Directional Indicator. With the +DI above the -DI, traders ma...

Read more

Acasti Pharma Inc. (NASDAQ:ACST) shares have moved 27.78% on the week. The stock closed the most recent session at $1.15 after seeing 746260 shares trade hands. This represents a change of 4.55% from ...

Read more

Analysts expect Acasti Pharma Inc. (NASDAQ:ACST) to report $-0.08 EPS on February, 12.They anticipate $0.23 EPS change or 74.19 % from last quarter's $-0.31...

Read more

Shares of Acasti Pharma (ACST) have been tilting lower over the past 13 weeks, revealing bearish momentum for the shares, as they have dipped -21.43% over the past quarter. Looking further out we note...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank